.png?sfvrsn=20dde0c2_0&MaxWidth=1030&MaxHeight=450&ScaleUp=false&Quality=High&Method=ResizeFitToAreaArguments&Signature=5F0C4C2F5616E89762BB4F733E2DC58AE7CB19CD "National Awards Covid-19")
Epidemic Preparedness
COVID-19 will not be the last pandemic we face.
With the rapid urbanisation, increasing human mobility and climate change, we are at an increasing risk of emergence of “Disease X”, a highly infectious and deadly global epidemic caused by a pathogen currently unknown. Preparing in peacetime to respond as early as possible in an outbreak is the most effective way to safeguard against the dire consequences of infectious diseases.
EP HTCO is open to collaborations in epidemic preparedness research for the development of new discoveries to improve health outcomes.
OUR R&D and TECHNOLOGIES
EP HTCO builds and strengthen innovative, multi-disciplinary research with potential impactful outcomes for epidemic preparedness across the four domains of detection, intervention, prevention and surveillance.
Detection - Diagnostic methods or biosensors to allow rapid, sensitive microbial identification, easily deployable for point-of-case testing, and cost-effective.
Intervention -Technologies to enable development of efficacious therapeutics or vaccines, against respiratory diseases, vector-borne diseases and anti-microbial resistance pathogens.
Prevention - Develop technologies or measures to mitigate the spread
Surveillance - Develop enabling technologies for the continuous, systematic collection, analysis, modelling and interpretation of health-related data needed for the planning, implementation, and evaluation of public health practice
Watch: Supporting National Pandemic Preparedness with Multi-Disciplinary Capabilities and Technologies
Prof Lisa Ng, Executive Director at A*STAR’s Infectious Diseases Horizontal Technology Coordinating Office (ID HTCO) and Dr Fong Siew-Wai, Research Scientist at A*STAR’s ID Labs share how the HTCO brings together A*STAR’s multi-disciplinary capabilities to combat infectious diseases like COVID-19, mosquito-borne viruses and more.
Features
- New A*Star outfit aims to nip any emerging pathogen in the bud
- Covid-19 vaccine could become like yearly flu shot, say experts on Straits Times' panel discussion
- Singapore a hub in region for malaria research
- Patients who have recovered from Covid-19 may be at risk of getting blood clots: Study
- Immunity to Covid-19 varies from 35 days to 4 decades among those infected: S'pore study
- Preparing for Disease X: Singapore to boost defences against future outbreaks in post-Covid-19 world
- Singapore researchers discover antibodies that neutralise coronavirus
- Asia’s Changemakers | Taking down the silent killers [VIDEO]
- Sensing emotions in a crisis
A*STAR celebrates International Women's Day
From groundbreaking discoveries to cutting-edge research, our researchers are empowering the next generation of female science, technology, engineering and mathematics (STEM) leaders.
Get inspired by our #WomeninSTEM